Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay

Patricia Connolly, Chadi Hage, J. Ryan Bariola, Eric Bensadoun, Mark Rodgers, Robert W. Bradsher, L. Joseph Wheat

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

The second-generation MVista Blastomyces antigen enzyme immunoassay was not quantitative; therefore, specimens obtained previously were tested in the same assay as new specimens to assess the change in antigen levels. Furthermore, the sensitivity in serum had not been fully evaluated. The purpose of this study was to evaluate a quantitative Blastomyces antigen assay and detection of antigen in serum. Calibrators containing known concentrations of Blastomyces galactomannan were used to quantify antigen in urine and serum from patients with proven blastomycosis and from controls. Paired current and previously obtained urine specimens were tested to determine if quantification eliminated the need for concurrent testing to assess change in antigen. Pretreatment of serum with EDTA at 104°C was evaluated to determine if dissociation of immune complexes improved detection of antigenemia. Antigenuria was detected in 89.9% of patients with culture- or histopathology-proven blastomycosis. Specificity was 99.0% in patients with nonfungal infections and healthy subjects, but cross-reactions occurred in 95.6% of patients with histoplasmosis. Change in antigen level categorized as increase, no change, or decrease based on antigen units determined in the same assay agreed closely with the category of change in ng/ml determined from different assays. Pretreatment increased the sensitivity of detection of antigenemia from 35.7% to 57.1%. Quantification eliminated the need for concurrent testing of current and previously obtained specimens for assessment of changes in antigen concentration. Pretreatment increased the sensitivity for detection of antigenemia. Differentiation of histoplasmosis and blastomycosis is not possible by antigen detection.

Original languageEnglish
Pages (from-to)53-56
Number of pages4
JournalClinical and Vaccine Immunology
Volume19
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Blastomyces
Immunoenzyme Techniques
Antigens
Enzymes
Blastomycosis
Assays
Histoplasmosis
Serum
Urine
Cross Reactions
Testing
Antigen-Antibody Complex
Edetic Acid
Healthy Volunteers

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Connolly, P., Hage, C., Bariola, J. R., Bensadoun, E., Rodgers, M., Bradsher, R. W., & Wheat, L. J. (2012). Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay. Clinical and Vaccine Immunology, 19(1), 53-56. https://doi.org/10.1128/CVI.05248-11

Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay. / Connolly, Patricia; Hage, Chadi; Bariola, J. Ryan; Bensadoun, Eric; Rodgers, Mark; Bradsher, Robert W.; Wheat, L. Joseph.

In: Clinical and Vaccine Immunology, Vol. 19, No. 1, 01.2012, p. 53-56.

Research output: Contribution to journalArticle

Connolly, P, Hage, C, Bariola, JR, Bensadoun, E, Rodgers, M, Bradsher, RW & Wheat, LJ 2012, 'Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay', Clinical and Vaccine Immunology, vol. 19, no. 1, pp. 53-56. https://doi.org/10.1128/CVI.05248-11
Connolly, Patricia ; Hage, Chadi ; Bariola, J. Ryan ; Bensadoun, Eric ; Rodgers, Mark ; Bradsher, Robert W. ; Wheat, L. Joseph. / Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay. In: Clinical and Vaccine Immunology. 2012 ; Vol. 19, No. 1. pp. 53-56.
@article{092ae48705874b5bbfed01cbbc5db83b,
title = "Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay",
abstract = "The second-generation MVista Blastomyces antigen enzyme immunoassay was not quantitative; therefore, specimens obtained previously were tested in the same assay as new specimens to assess the change in antigen levels. Furthermore, the sensitivity in serum had not been fully evaluated. The purpose of this study was to evaluate a quantitative Blastomyces antigen assay and detection of antigen in serum. Calibrators containing known concentrations of Blastomyces galactomannan were used to quantify antigen in urine and serum from patients with proven blastomycosis and from controls. Paired current and previously obtained urine specimens were tested to determine if quantification eliminated the need for concurrent testing to assess change in antigen. Pretreatment of serum with EDTA at 104°C was evaluated to determine if dissociation of immune complexes improved detection of antigenemia. Antigenuria was detected in 89.9{\%} of patients with culture- or histopathology-proven blastomycosis. Specificity was 99.0{\%} in patients with nonfungal infections and healthy subjects, but cross-reactions occurred in 95.6{\%} of patients with histoplasmosis. Change in antigen level categorized as increase, no change, or decrease based on antigen units determined in the same assay agreed closely with the category of change in ng/ml determined from different assays. Pretreatment increased the sensitivity of detection of antigenemia from 35.7{\%} to 57.1{\%}. Quantification eliminated the need for concurrent testing of current and previously obtained specimens for assessment of changes in antigen concentration. Pretreatment increased the sensitivity for detection of antigenemia. Differentiation of histoplasmosis and blastomycosis is not possible by antigen detection.",
author = "Patricia Connolly and Chadi Hage and Bariola, {J. Ryan} and Eric Bensadoun and Mark Rodgers and Bradsher, {Robert W.} and Wheat, {L. Joseph}",
year = "2012",
month = "1",
doi = "10.1128/CVI.05248-11",
language = "English",
volume = "19",
pages = "53--56",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Blastomyces dermatitidis antigen detection by quantitative enzyme immunoassay

AU - Connolly, Patricia

AU - Hage, Chadi

AU - Bariola, J. Ryan

AU - Bensadoun, Eric

AU - Rodgers, Mark

AU - Bradsher, Robert W.

AU - Wheat, L. Joseph

PY - 2012/1

Y1 - 2012/1

N2 - The second-generation MVista Blastomyces antigen enzyme immunoassay was not quantitative; therefore, specimens obtained previously were tested in the same assay as new specimens to assess the change in antigen levels. Furthermore, the sensitivity in serum had not been fully evaluated. The purpose of this study was to evaluate a quantitative Blastomyces antigen assay and detection of antigen in serum. Calibrators containing known concentrations of Blastomyces galactomannan were used to quantify antigen in urine and serum from patients with proven blastomycosis and from controls. Paired current and previously obtained urine specimens were tested to determine if quantification eliminated the need for concurrent testing to assess change in antigen. Pretreatment of serum with EDTA at 104°C was evaluated to determine if dissociation of immune complexes improved detection of antigenemia. Antigenuria was detected in 89.9% of patients with culture- or histopathology-proven blastomycosis. Specificity was 99.0% in patients with nonfungal infections and healthy subjects, but cross-reactions occurred in 95.6% of patients with histoplasmosis. Change in antigen level categorized as increase, no change, or decrease based on antigen units determined in the same assay agreed closely with the category of change in ng/ml determined from different assays. Pretreatment increased the sensitivity of detection of antigenemia from 35.7% to 57.1%. Quantification eliminated the need for concurrent testing of current and previously obtained specimens for assessment of changes in antigen concentration. Pretreatment increased the sensitivity for detection of antigenemia. Differentiation of histoplasmosis and blastomycosis is not possible by antigen detection.

AB - The second-generation MVista Blastomyces antigen enzyme immunoassay was not quantitative; therefore, specimens obtained previously were tested in the same assay as new specimens to assess the change in antigen levels. Furthermore, the sensitivity in serum had not been fully evaluated. The purpose of this study was to evaluate a quantitative Blastomyces antigen assay and detection of antigen in serum. Calibrators containing known concentrations of Blastomyces galactomannan were used to quantify antigen in urine and serum from patients with proven blastomycosis and from controls. Paired current and previously obtained urine specimens were tested to determine if quantification eliminated the need for concurrent testing to assess change in antigen. Pretreatment of serum with EDTA at 104°C was evaluated to determine if dissociation of immune complexes improved detection of antigenemia. Antigenuria was detected in 89.9% of patients with culture- or histopathology-proven blastomycosis. Specificity was 99.0% in patients with nonfungal infections and healthy subjects, but cross-reactions occurred in 95.6% of patients with histoplasmosis. Change in antigen level categorized as increase, no change, or decrease based on antigen units determined in the same assay agreed closely with the category of change in ng/ml determined from different assays. Pretreatment increased the sensitivity of detection of antigenemia from 35.7% to 57.1%. Quantification eliminated the need for concurrent testing of current and previously obtained specimens for assessment of changes in antigen concentration. Pretreatment increased the sensitivity for detection of antigenemia. Differentiation of histoplasmosis and blastomycosis is not possible by antigen detection.

UR - http://www.scopus.com/inward/record.url?scp=84855708242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855708242&partnerID=8YFLogxK

U2 - 10.1128/CVI.05248-11

DO - 10.1128/CVI.05248-11

M3 - Article

C2 - 22116687

AN - SCOPUS:84855708242

VL - 19

SP - 53

EP - 56

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 1

ER -